{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:59:49Z","timestamp":1780343989085,"version":"3.54.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Black race has been used to guide antihypertensive drug selection for Black patients based on predominant between race (same drug) and intra-race (different drugs) blood pressure (BP) response patterns. Accordingly, thiazide diuretics and calcium antagonists have been recommended over renin-angiotensin system (RAS) inhibitors (angiotensin-receptor blockers, angiotensin-converting enzyme inhibitors) and beta blockers for Black patients. Current antihypertensive drug prescribing reflects historical guidance as calcium antagonists and thiazide diuretics are prescribed more and RAS blockers less in Black than White patients. Hypertension control rates in Blacks, lag those for Whites despite their greater use of combination drug therapy and lesser use of monotherapy. This is also true across drug regimens containing any of the 4 recommended classes for initial therapy as well as for evidence-based combination drug therapy (calcium antagonist or thiazide diuretic\u2005+\u2005RAS blocker) regimens for which there is no known racial disparity in BP response. Current recommendations acknowledge the need for combination drug therapy in most, especially in Black patients. One exemplary comprehensive hypertension control program achieved &amp;gt;80% control rates in Black and White patients with minimal racial disparity while utilizing a race-agnostic therapeutic algorithm. Black patients manifest robust, if not outsized, BP responses to diet\/lifestyle modifications. Importantly, race neither appears to be a necessary nor sufficient consideration for the selection of effective drug therapy. Accordingly, we urge the initiation of adequately intense race-agnostic drug therapy coupled with greater emphasis on diet\/lifestyle modifications for Black patients as the cornerstone of a race-informed approach to hypertension therapeutics.<\/jats:p>","DOI":"10.1093\/ajh\/hpae093","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:40:33Z","timestamp":1721292033000},"page":"739-744","source":"Crossref","is-referenced-by-count":10,"title":["Evolving the Role of Black Race in Hypertension Therapeutics"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-5598","authenticated-orcid":false,"given":"John M","family":"Flack","sequence":"first","affiliation":[{"name":"Hypertension Section, Division of General Internal Medicine, Department of Medicine, Southern Illinois University School of Medicine , Springfield IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bitner","sequence":"additional","affiliation":[{"name":"Hypertension Section, Division of General Internal Medicine, Department of Medicine, Southern Illinois University School of Medicine , Springfield IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buhnerkempe","sequence":"additional","affiliation":[{"name":"Department of Medicine, Center for Clinical Research, Southern Illinois University School of Medicine , Springfield, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"2024091605504643200_CIT0001","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-141-8-200410190-00009","article-title":"Systematic review: antihypertensive drug therapy in black patients","volume":"141","author":"Brewster","year":"2004","journal-title":"Ann Intern Med"},{"key":"2024091605504643200_CIT0002","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","article-title":"Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement","volume":"56","author":"Flack","year":"2010","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0003","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinte.1990.00040031707020","article-title":"A comparison of the efficacy and safety of a beta blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks","volume":"150","author":"Saunders","year":"1990","journal-title":"Arch Intern Med"},{"key":"2024091605504643200_CIT0004","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.160.12.1842","article-title":"The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the quinapril titration interval management evaluation (ATIME) study. ATIME research group","volume":"160","author":"Flack","year":"2000","journal-title":"Arch Intern Med"},{"key":"2024091605504643200_CIT0005","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0149-2918(01)80101-6","article-title":"Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension","volume":"23","author":"Flack","year":"2001","journal-title":"Clin Ther"},{"key":"2024091605504643200_CIT0006","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3109\/10641969309037087","article-title":"Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments","volume":"15","author":"Salako","year":"1993","journal-title":"Clin Exp Hypertens"},{"key":"2024091605504643200_CIT0007","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/clpt.1990.210","article-title":"Combined alpha\/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients","volume":"48","author":"Townsend","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"2024091605504643200_CIT0008","first-page":"730","article-title":"Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patients","volume":"14","author":"Weir","year":"1992","journal-title":"Clin Ther"},{"key":"2024091605504643200_CIT0009","doi-asserted-by":"crossref","first-page":"103G","DOI":"10.1016\/0002-9149(88)90041-0","article-title":"Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension","volume":"62","author":"Wolfson","year":"1988","journal-title":"Am J Cardiol"},{"key":"2024091605504643200_CIT0010","first-page":"e484","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"2024091605504643200_CIT0011","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial mono- and combination therapy and hypertension control the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0012","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.HYP.0000127924.67353.86","article-title":"Determinants of blood pressure response to quinapril in black and white hypertensive patients","volume":"43","author":"Mokwe","year":"2004","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0013","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.HYP.0000118019.28487.9c","article-title":"Overlap between whites and blacks in response to antihypertensive drugs","volume":"43","author":"Sehgal","year":"2004","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0014","article-title":"Demographic Turning Points for the United States: Population Projections for 2020 to 2060","author":"Vespa"},{"key":"2024091605504643200_CIT0015","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2024091605504643200_CIT0016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamacardio.2022.2345","article-title":"Age at diagnosis of hypertension by race and ethnicity in the US from 2011 to 2020","volume":"7","author":"Huang","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"14","key":"2024091605504643200_CIT0017","doi-asserted-by":"crossref","first-page":"e007988","DOI":"10.1161\/JAHA.117.007988","article-title":"Cumulative incidence of hypertension by 55 years of age in blacks and whites: The CARDIA study","volume":"7","author":"Thomas","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024091605504643200_CIT0018","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7015-3-2","article-title":"An International comparative study of blood pressure in populations of European vs. African descent","volume":"3","author":"Cooper","year":"2005","journal-title":"BMC Med"},{"key":"2024091605504643200_CIT0019","doi-asserted-by":"crossref","first-page":"e1959","DOI":"10.1097\/MD.0000000000001959","article-title":"Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis","volume":"94","author":"Sarki","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"2024091605504643200_CIT0020","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1097\/HJH.0000000000001489","article-title":"Hypertension among US-born and foreign-born non-Hispanic Blacks: National Health and Nutrition Examination Survey 2003\u20132014 data","volume":"35","author":"Brown","year":"2017","journal-title":"J Hypertens"},{"key":"2024091605504643200_CIT0021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"2024091605504643200_CIT0022","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States","volume":"73","author":"Carey","year":"2019","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0023","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HJH.0000000000002103","article-title":"Prevalence of refractory hypertension in the United States from 1999 to 2014","volume":"37","author":"Buhnerkempe","year":"2019","journal-title":"J Hypertens"},{"key":"2024091605504643200_CIT0024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/HYPERTENSIONAHA.120.15064","article-title":"Adverse health outcomes associated with refractory and treatment-resistant hypertension in the chronic renal insufficiency cohort","volume":"77","author":"Buhnerkempe","year":"2021","journal-title":"Hypertension"},{"issue":"8","key":"2024091605504643200_CIT0025","doi-asserted-by":"crossref","first-page":"106628","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106628","article-title":"Black-white differences in left ventricular hypertrophy rates among young adults with ischemic stroke","volume":"31","author":"Hou","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2024091605504643200_CIT0026","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/CIRCULATIONAHA.119.043628","article-title":"Racial differences in malignant left ventricular hypertrophy and incidence of heart failure: a multi-cohort study","volume":"141","author":"Lewis","year":"2020","journal-title":"Circulation"},{"key":"2024091605504643200_CIT0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.HYP.0000169972.96201.8e","article-title":"Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The Dallas Heart study","volume":"46","author":"Drazner","year":"2005","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0028","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HCO.0000000000000855","article-title":"Racial and ethnic disparities in heart failure: current state and future directions","volume":"36","author":"Lewsey","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"2024091605504643200_CIT0029","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Arch Intern Med"},{"key":"2024091605504643200_CIT0030","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1161\/STROKEAHA.120.030426","article-title":"Considerations in addressing social determinants of health to reduce race\/ethnic disparities in stroke outcomes in the United States","volume":"51","author":"Skolarus","year":"2020","journal-title":"Stroke"},{"key":"2024091605504643200_CIT0031","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamaneurol.2020.0010","article-title":"Association of black race with early recurrence after minor ischemic stroke or transient ischemic attack: secondary analysis of the POINT randomized clinical trial","volume":"77","author":"Kamel","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024091605504643200_CIT0032","first-page":"A7","article-title":"US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Diseases in the United States","volume-title":"Am J Kidney Dis","author":"Johansen","year":"2021"},{"key":"2024091605504643200_CIT0033","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/VHRM.S416395","article-title":"Racial differences and contributory cardiovascular and non-cardiovascular factors towards chronic kidney disease progression","volume":"19","author":"Choi","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"2024091605504643200_CIT0034","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"2024091605504643200_CIT0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/HYPERTENSIONAHA.121.17102","article-title":"Self-reported antihypertensive medication class and temporal relationship to treatment guidelines","volume":"79","author":"Egan","year":"2022","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0036","volume-title":"Dietary Guidelines for Americans, 2020\u20132025","author":"United States Dietary Guidelines Advisory Committee","year":"2020"},{"key":"2024091605504643200_CIT0037","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2018.1156","article-title":"Estimated 24-hour urinary sodium and potassium excretion in US adults","volume":"319","author":"Cogswell","year":"2018","journal-title":"JAMA"},{"key":"2024091605504643200_CIT0038","doi-asserted-by":"crossref","first-page":"e015719","DOI":"10.1161\/JAHA.119.015719","article-title":"Potassium intake and blood pressure: a dose\u2013response meta-analysis of randomized controlled trials","volume":"9","author":"Filippini","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024091605504643200_CIT0039","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archinte.1996.00440010079010","article-title":"Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial","volume":"156","author":"Brancati","year":"1996","journal-title":"Arch Intern Med"},{"key":"2024091605504643200_CIT0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.33.1.18","article-title":"Normotensive salt sensitivity: effects of race and dietary potassium","volume":"33","author":"Morris","year":"1999","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"2024091605504643200_CIT0042","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.109.914721","article-title":"Physical activity and cardiovascular health","volume":"122","author":"Shiroma","year":"2010","journal-title":"Circulation"},{"key":"2024091605504643200_CIT0043","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1249\/MSS.0b013e31827d87ec","article-title":"Physical activity and cardiovascular disease in African Americans in ARIC","volume":"45","author":"Bell","year":"2013","journal-title":"Med Sci Sports Exerc"},{"key":"2024091605504643200_CIT0044","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ypmed.2016.05.009","article-title":"Prevalence and trends in physical activity among older adults in the United States: a comparison across three national surveys","volume":"89","author":"Keadle","year":"2016","journal-title":"Prev Med"},{"key":"2024091605504643200_CIT0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amepre.2010.12.016","article-title":"Physical activity in US Adults: compliance with the physical activity guidelines for Americans","volume":"40","author":"Tucker","year":"2011","journal-title":"Am J Prev Med"},{"key":"2024091605504643200_CIT0046","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/HYPERTENSIONAHA.116.08398","article-title":"Physical activity and incident hypertension in African Americans","volume":"69","author":"Diaz","year":"2017","journal-title":"Hypertension"},{"key":"2024091605504643200_CIT0047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7812\/TPP\/15-052","article-title":"Population care management and team-based approach to reduce racial disparities among African Americans\/Blacks with hypertension","volume":"20","author":"Bartolome","year":"2016","journal-title":"Perm J"},{"issue":"1","key":"2024091605504643200_CIT0048","doi-asserted-by":"crossref","first-page":"e2249930","DOI":"10.1001\/jamanetworkopen.2022.49930","article-title":"Blood pressure control among black and white adults following a quality improvement program in a large integrated health system","volume":"6","author":"Harrison","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024091605504643200_CIT0049","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential U.S. population impact of the 2017 American College of Cardiology\/American Heart Association high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpae093\/58697862\/hpae093.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/37\/10\/739\/58922526\/hpae093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/37\/10\/739\/58922526\/hpae093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:51:14Z","timestamp":1726465874000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/37\/10\/739\/7716237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,7,18]]},"published-print":{"date-parts":[[2024,9,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpae093","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,7,18]]}}}